When they came up with “Common Side Effects,” Bennett recalled in a recent interview, he was thinking about their prominence ...

"Make America Healthy Again" (MAHA) became a rallying cry during the final months of the 2024 presidential election, after ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

All three cannabinoids reduced the electrical activity linked to Nav1.8, but CBG had the strongest effect. This suggests that CBG could be the most promising candidate for developing new pain ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

Offering image-guided superficial radiation therapy to rural populations could mend health disparities in nonmelanoma skin cancer treatment, according to a study published in Cancers.Historically, ...

BCG therapy is associated with a high frequency of side effects in NMIBC; however, when used in sequential combination with ...

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.

On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.